Vorasidenib,
1644545-52-7,
UNII-789Q85GA8P,
789Q85GA8P,
AG-881,
6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine,
AG881,
9UO,
Vorasidenib [INN],
AG-881; Vorasidenib,
Vorasidenib (AG-881),
AG 881 [WHO-DD],
SCHEMBL16393139,
QCZAWDGAVJMPTA-RNFRBKRXSA-N,
BDBM279948,
EX-A2574,
AG 881,
s8611,
US10028961, Compound 101,
CS-8033,
HY-104042,
A16908,
1,3,5-Triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-N2,N4-bis((1R)-2,2,2-trifluoro-1-methylethyl)-,
6-(6-chloropyridin-2-yl)-N~2~,N~4~-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine,
6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoro propan-2-yl)-1,3,5-triazine-2,4-diamine,
6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoropropan-2-yl)-1,3,5-triazine-2,4-diamine,
PF06291874,